drugset / Trial / NCT00620022

The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT00620022

Phase 3 Completed 90 enrolled Novartis
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study compared the effect of indacaterol (300 μg once daily \[od\]) on exercise endurance with that of placebo in patients with moderate to severe chronic obstructive pulmonary disease.

Timeline

Start
2008-04
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Indacaterol Other / unclassified 300 ug Inhaled